Recurrent  ||| S:0 E:10 ||| FW
posterior  ||| S:10 E:20 ||| FW
reversible  ||| S:20 E:31 ||| FW
encephalopathy  ||| S:31 E:46 ||| FW
due  ||| S:46 E:50 ||| JJ
to  ||| S:50 E:53 ||| TO
vasospasm  ||| S:53 E:63 ||| VB
and  ||| S:63 E:67 ||| CC
cerebral  ||| S:67 E:76 ||| JJ
hypoperfusionin  ||| S:76 E:92 ||| NN
in  ||| S:92 E:95 ||| IN
acute  ||| S:95 E:101 ||| JJ
leukemia ||| S:101 E:109 ||| NN
:  ||| S:109 E:111 ||| :
a  ||| S:111 E:113 ||| DT
case  ||| S:113 E:118 ||| NN
report  ||| S:118 E:125 ||| NN
We  ||| S:125 E:128 ||| PRP
report  ||| S:128 E:135 ||| VBP
the  ||| S:135 E:139 ||| DT
case  ||| S:139 E:144 ||| NN
of  ||| S:144 E:147 ||| IN
a  ||| S:147 E:149 ||| DT
4-year-old  ||| S:149 E:160 ||| JJ
girl  ||| S:160 E:165 ||| NN
who  ||| S:165 E:169 ||| WP
presented  ||| S:169 E:179 ||| VBD
with  ||| S:179 E:184 ||| IN
recurrent  ||| S:184 E:194 ||| FW
posterior  ||| S:194 E:204 ||| FW
reversible  ||| S:204 E:215 ||| FW
encephalopathy  ||| S:215 E:230 ||| FW
syndrome  ||| S:230 E:239 ||| FW
( ||| S:239 E:240 ||| -LRB-
PRES ||| S:240 E:244 ||| NNP
) ||| S:244 E:245 ||| -RRB-
.  ||| S:245 E:247 ||| .
She  ||| S:247 E:251 ||| PRP
was  ||| S:251 E:255 ||| VBD
diagnosed  ||| S:255 E:265 ||| VBN
with  ||| S:265 E:270 ||| IN
B-precursor  ||| S:270 E:282 ||| JJ
acute  ||| S:282 E:288 ||| JJ
lymphocytic  ||| S:288 E:300 ||| JJ
leukemia  ||| S:300 E:309 ||| NN
( ||| S:309 E:310 ||| -LRB-
ALL ||| S:310 E:313 ||| NNP
) ||| S:313 E:314 ||| -RRB-
,  ||| S:314 E:316 ||| ,
and  ||| S:316 E:320 ||| CC
was  ||| S:320 E:324 ||| VBD
administered  ||| S:324 E:337 ||| VBN
remission-induction  ||| S:337 E:357 ||| JJ
chemotherapy ||| S:357 E:369 ||| NN
.  ||| S:369 E:371 ||| .
On  ||| S:371 E:374 ||| IN
day  ||| S:374 E:378 ||| NN
28  ||| S:378 E:381 ||| CD
of  ||| S:381 E:384 ||| IN
the  ||| S:384 E:388 ||| DT
induction  ||| S:388 E:398 ||| JJ
therapy ||| S:398 E:405 ||| NN
,  ||| S:405 E:407 ||| ,
she  ||| S:407 E:411 ||| PRP
experienced  ||| S:411 E:423 ||| VBD
seizure  ||| S:423 E:431 ||| NN
and  ||| S:431 E:435 ||| CC
prolonged  ||| S:435 E:445 ||| JJ
unconsciousness ||| S:445 E:460 ||| NN
.  ||| S:460 E:462 ||| .
Blood  ||| S:462 E:468 ||| NN
pressure  ||| S:468 E:477 ||| NN
was  ||| S:477 E:481 ||| VBD
slightly  ||| S:481 E:490 ||| RB
elevated ||| S:490 E:498 ||| VBD
.  ||| S:498 E:500 ||| .
MRI  ||| S:500 E:504 ||| NNP
revealed  ||| S:504 E:513 ||| VBD
cortical  ||| S:513 E:522 ||| JJ
cytotoxic  ||| S:522 E:532 ||| JJ
edema  ||| S:532 E:538 ||| NN
in  ||| S:538 E:541 ||| IN
the  ||| S:541 E:545 ||| DT
right  ||| S:545 E:551 ||| JJ
temporal  ||| S:551 E:560 ||| NN
and  ||| S:560 E:564 ||| CC
occipital  ||| S:564 E:574 ||| JJ
lobes ||| S:574 E:579 ||| NN
.  ||| S:579 E:581 ||| .
In  ||| S:581 E:584 ||| IN
the  ||| S:584 E:588 ||| DT
right  ||| S:588 E:594 ||| JJ
occipital  ||| S:594 E:604 ||| JJ
white  ||| S:604 E:610 ||| JJ
matter  ||| S:610 E:617 ||| NN
the  ||| S:617 E:621 ||| DT
lesion  ||| S:621 E:628 ||| NN
with  ||| S:628 E:633 ||| IN
vasogenic  ||| S:633 E:643 ||| JJ
edema  ||| S:643 E:649 ||| NNS
also  ||| S:649 E:654 ||| RB
existed ||| S:654 E:661 ||| VBN
.  ||| S:661 E:663 ||| .
Three  ||| S:663 E:669 ||| CD
days  ||| S:669 E:674 ||| NNS
later ||| S:674 E:679 ||| RB
,  ||| S:679 E:681 ||| ,
MRI  ||| S:681 E:685 ||| NNP
showed  ||| S:685 E:692 ||| VBD
vasogenic  ||| S:692 E:702 ||| JJ
edema  ||| S:702 E:708 ||| NN
in  ||| S:708 E:711 ||| IN
subcortical  ||| S:711 E:723 ||| JJ
white  ||| S:723 E:729 ||| JJ
matter  ||| S:729 E:736 ||| NN
of  ||| S:736 E:739 ||| IN
the  ||| S:739 E:743 ||| DT
right  ||| S:743 E:749 ||| JJ
temporal  ||| S:749 E:758 ||| JJ
right  ||| S:758 E:764 ||| NN
occipital  ||| S:764 E:774 ||| NNS
and  ||| S:774 E:778 ||| CC
bilateral  ||| S:778 E:788 ||| JJ
occipital  ||| S:788 E:798 ||| JJ
lobes ||| S:798 E:803 ||| NN
.  ||| S:803 E:805 ||| .
The  ||| S:805 E:809 ||| DT
lesions  ||| S:809 E:817 ||| NN
had  ||| S:817 E:821 ||| VBD
receded  ||| S:821 E:829 ||| VBN
with  ||| S:829 E:834 ||| IN
time ||| S:834 E:838 ||| NN
.  ||| S:838 E:840 ||| .
Since  ||| S:840 E:846 ||| IN
the  ||| S:846 E:850 ||| DT
seizure  ||| S:850 E:858 ||| NN
occurred ||| S:858 E:866 ||| VBD
,  ||| S:866 E:868 ||| ,
the  ||| S:868 E:872 ||| DT
chemotherapy  ||| S:872 E:885 ||| NN
had  ||| S:885 E:889 ||| VBD
been  ||| S:889 E:894 ||| VBN
discontinued ||| S:894 E:906 ||| VBN
.  ||| S:906 E:908 ||| .
The  ||| S:908 E:912 ||| DT
episodes  ||| S:912 E:921 ||| NNS
of  ||| S:921 E:924 ||| IN
seizure  ||| S:924 E:932 ||| NN
and  ||| S:932 E:936 ||| CC
prolonged  ||| S:936 E:946 ||| JJ
consciousness  ||| S:946 E:960 ||| NN
recurred  ||| S:960 E:969 ||| VBD
22  ||| S:969 E:972 ||| CD
days  ||| S:972 E:977 ||| NNS
later ||| S:977 E:982 ||| RB
.  ||| S:982 E:984 ||| .
MRI  ||| S:984 E:988 ||| NNP
revealed  ||| S:988 E:997 ||| VBD
vasogenic  ||| S:997 E:1007 ||| JJ
edema  ||| S:1007 E:1013 ||| NN
in  ||| S:1013 E:1016 ||| IN
the  ||| S:1016 E:1020 ||| DT
right  ||| S:1020 E:1026 ||| JJ
occipital  ||| S:1026 E:1036 ||| JJ
lobe ||| S:1036 E:1040 ||| NN
,  ||| S:1040 E:1042 ||| ,
and  ||| S:1042 E:1046 ||| CC
MR  ||| S:1046 E:1049 ||| NNP
angiography  ||| S:1049 E:1061 ||| FW
demonstrated  ||| S:1061 E:1074 ||| FW
vessel  ||| S:1074 E:1081 ||| FW
irregularity  ||| S:1081 E:1094 ||| FW
and  ||| S:1094 E:1098 ||| CC
reduced  ||| S:1098 E:1106 ||| JJ
branch  ||| S:1106 E:1113 ||| NN
visualization  ||| S:1113 E:1127 ||| NN
in  ||| S:1127 E:1130 ||| IN
the  ||| S:1130 E:1134 ||| DT
middle  ||| S:1134 E:1141 ||| NN
and  ||| S:1141 E:1145 ||| CC
posterior  ||| S:1145 E:1155 ||| JJ
cerebral  ||| S:1155 E:1164 ||| JJ
arteries ||| S:1164 E:1172 ||| NNS
.  ||| S:1172 E:1174 ||| .
Arterial  ||| S:1174 E:1183 ||| NNP
spin-labeling  ||| S:1183 E:1197 ||| NNP
( ||| S:1197 E:1198 ||| -LRB-
ASL ||| S:1198 E:1201 ||| NNP
)  ||| S:1201 E:1203 ||| -RRB-
showed  ||| S:1203 E:1210 ||| VBD
hypoperfusion  ||| S:1210 E:1224 ||| VBN
in  ||| S:1224 E:1227 ||| IN
both  ||| S:1227 E:1232 ||| DT
occipital  ||| S:1232 E:1242 ||| JJ
lobes ||| S:1242 E:1247 ||| NN
.  ||| S:1247 E:1249 ||| .
It  ||| S:1249 E:1252 ||| PRP
suggests  ||| S:1252 E:1261 ||| VBZ
that  ||| S:1261 E:1266 ||| DT
vasoconstriction  ||| S:1266 E:1283 ||| NN
and  ||| S:1283 E:1287 ||| CC
hypoperfusion  ||| S:1287 E:1301 ||| NNS
could  ||| S:1301 E:1307 ||| MD
lead  ||| S:1307 E:1312 ||| VB
to  ||| S:1312 E:1315 ||| TO
recurrent  ||| S:1315 E:1325 ||| VB
PRES  ||| S:1325 E:1330 ||| NNP
in  ||| S:1330 E:1333 ||| IN
this  ||| S:1333 E:1338 ||| DT
case ||| S:1338 E:1342 ||| NN
.  ||| S:1342 E:1344 ||| .
It  ||| S:1344 E:1347 ||| PRP
is  ||| S:1347 E:1350 ||| VBZ
possible  ||| S:1350 E:1359 ||| JJ
that  ||| S:1359 E:1364 ||| IN
ASL  ||| S:1364 E:1368 ||| NNP
might  ||| S:1368 E:1374 ||| MD
be  ||| S:1374 E:1377 ||| VB
more  ||| S:1377 E:1382 ||| RBR
sensitive  ||| S:1382 E:1392 ||| JJ
than  ||| S:1392 E:1397 ||| IN
MRI  ||| S:1397 E:1401 ||| NNP
in  ||| S:1401 E:1404 ||| IN
detecting  ||| S:1404 E:1414 ||| VBG
the  ||| S:1414 E:1418 ||| DT
lesions  ||| S:1418 E:1426 ||| NN
of  ||| S:1426 E:1429 ||| IN
PRES ||| S:1429 E:1433 ||| NNP
.  ||| S:1433 E:1435 ||| .
It  ||| S:1435 E:1438 ||| PRP
should  ||| S:1438 E:1445 ||| MD
be  ||| S:1445 E:1448 ||| VB
noted  ||| S:1448 E:1454 ||| VBN
that  ||| S:1454 E:1459 ||| IN
PRES  ||| S:1459 E:1464 ||| NNP
might  ||| S:1464 E:1470 ||| MD
recur  ||| S:1470 E:1476 ||| VB
in  ||| S:1476 E:1479 ||| IN
leukemia ||| S:1479 E:1487 ||| NN
.  ||| S:1487 E:1489 ||| .
